Telemonitoramento de idosos usuários de anticoagulante durante a pandemia da COVID-19
Authors:
- Lívia Cristina FerreiraLFLívia Cristina Ferreira
- Nelson Machado Do Carmo JúniorNJNelson Machado Do Carmo Júnior
- Gabriel Gomes Soares Lins PeixotoGPGabriel Gomes Soares Lins Peixoto
- Ana Luiza Pereira AguiarAAAna Luiza Pereira Aguiar
- Estevão Alves ValleEVEstevão Alves Valle
- Daniela Castelo AzevedoDADaniela Castelo Azevedo
- Mariana Martins Gonzaga Do NascimentoMariana Martins Gonzaga Do Nascimento
Open Access
- 1 January 2023
- journal article
- research article
- Published by Centro Universitario Sao Camilo - Sao Paulo in O Mundo da Saúde
- Vol. 47 (1)
Abstract
The COVID-19 pandemic brought challenges to the monitoring of anticoagulant users, especially older adults, making telemonitoring an alternative to provide continuity of care for these patients. The present study aimed to describe the experience of telemonitoring of older anticoagulant users during the COVID-19 pandemic. This is a descriptive study concerning the telemonitoring pharmaceutical service for older adults (≥60 years old) using oral anticoagulants in a private geriatric outpatient clinic (Belo Horizonte). Older people had parameters of effectiveness and safety of anticoagulants monitored monthly by telephone (Apr-Dec/2021). Identified problems generated interventions for the patient or the multidisciplinary team. A total of 425 older adults were included in the service. Most used apixaban (189;41.9%), rivaroxaban (146;34.4%) and warfarin (47;11.1%). There was a mean age of 82.1 years, mostly female (65.2%), most at high risk of vulnerability (69%), and an incidence of 9.9% of COVID-19. There were 219 interventions related to warfarin (average of 4.6 interventions/patient); including requests for an INR test (57.5%), health guidelines (19.6%), dosage change (reduction - 10.5%; increase - 5.9%; suspension - 0.6%), or referral (5.9%). Users of other anticoagulants did not show alterations in the monitored parameters. Eleven older adults suffered falls and 10 required hospitalizations due to thromboembolic or hemorrhagic events. There was no statistically significant difference in hospitalization rates between users of warfarin or other anticoagulants (p=0.314). Monitoring older anticoagulant users is important, especially considering the high level of frailty identified and the thromboembolic and non-thromboembolic risks that COVID-19 brings. Telemonitoring was important, allowing for multiple interventions to be performed. A pandemia da COVID-19 trouxe desafios para o monitoramento de usuários de anticoagulantes, sobretudo idosos, sendo o telemonitoramento uma alternativa para dar continuidade aos cuidados para esses pacientes. O presente estudo teve como objetivo descrever a experiência do telemonitoramento de idosos usuários de anticoagulantes na pandemia da COVID-19. Trata-se de estudo referente ao serviço farmacêutico de telemonitoramento de idosos (≥60 anos) em uso de anticoagulantes orais em ambulatório de geriatria privado (Belo Horizonte). Idosos tiveram parâmetros de efetividade e segurança dos anticoagulantes monitorados mensalmente por telefone (abr-dez/2021). Problemas identificados geraram intervenções ao paciente ou equipe multiprofissional. Ao total 425 idosos foram incluídos no serviço. A maioria usava apixabana (189;41,9%), rivaroxabana (146;34,4%) e varfarina (47;11,1%). Observou-se média de idade de 82,1 anos, maioria feminina (65,2%), maioria com alto risco de vulnerabilidade (69%), e incidência de 9,9% de COVID-19. Realizou-se 219 intervenções relativas à varfarina (média de 4,6 intervenções/paciente); referiram-se à solicitação de exame de RNI (57,5%), orientações em saúde (19,6%), alteração da dose (redução - 10,5%; aumento - 5,9%; suspensão - 0,6%), ou encaminhamento (5,9%). Usuários de outros anticoagulantes não apresentaram alterações nos parâmetros acompanhados. Onze idosos sofreram quedas e 10 demandaram internação por eventos tromboembólicos ou hemorrágicos. Não houve diferença estatisticamente significativa nas proporções de internação entre usuários de varfarina ou outros anticoagulantes (p=0,314). Acompanhar idosos usuários de anticoagulantes é importante, sobretudo considerando-se o alto nível de fragilidade identificado e os riscos tromboembólicos e não-tromboembólicos que a COVID-19 traz. O telemonitoramento foi importante, permitindo realização de múltiplas intervenções.Keywords
This publication has 20 references indexed in Scilit:
- Pharmacists’ interventions improve health-related quality of life of rural older person on warfarin: a randomized controlled trialScientific Reports, 2021
- Outpatient management of chronic warfarin therapy at a pharmacist-run anticoagulation clinic during the COVID-19 pandemicJournal of Thrombosis and Thrombolysis, 2021
- Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forumJournal of Thrombosis and Thrombolysis, 2020
- Pharmacists’ influence on adverse reactions to warfarin: a randomised controlled trial in elderly rural patientsInternational Journal of Clinical Pharmacy, 2019
- Pharmacist’s interventions improve time in therapeutic range of elderly rural patients on warfarin therapy: a randomized trialInternational Journal of Clinical Pharmacy, 2018
- Outcomes of warfarin therapy managed by pharmacists via hospital anticoagulation clinic versus online anticoagulation clinicInternational Journal of Clinical Pharmacy, 2018
- Assessment of oral anticoagulation control at two pharmacist-managed clinics in BrazilInternational Journal of Clinical Pharmacy, 2017
- Impact of clinical pharmacist intervention in anticoagulation clinic in SudanInternational Journal of Clinical Pharmacy, 2017
- Collaborative home medicines review delays time to next hospitalization for warfarin associated bleeding in Australian war veteransJournal of Clinical Pharmacy and Therapeutics, 2011
- The impact of pharmacist-managed oral anticoagulation therapy in older veteransJournal of Clinical Pharmacy and Therapeutics, 2007